Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
Effient
Generic name / active ingredient
prasugrel
Dosage-form class
Prasugrel hydrochloride coated oral tablets: 5 mg and 10 mg (as listed in the U.S. public label; each in a 30-tablet bottle)
Route
Oral
Record reviewed
2026-08-23

Copy from the pack in hand

Source-linked reading points

  • Check EFFIENT, prasugrel, 5 mg or 10 mg, NDC, the 30-tablet bottle and target market together. mg is a labelled per-tablet amount, not a web rule for tablets per day, adding strengths, alternating them or replacing one pack with another.
  • Both 5 mg and 10 mg tablets in this label are unscored, and the label says not to break EFFIENT tablets. This product-specific wording does not automatically extend to another prasugrel product, market or oral tablet; swallowing, splitting or switching questions need pharmacist or prescriber review for the actual product.
  • The label has a serious-bleeding warning and identifies history of stroke/TIA, age, weight, prior bleeding, surgery or dental work and other medicines as information that needs a team with the complete history and medicine list. It is not a checklist for a webpage to decide whether anyone should continue, pause, make up or switch.
  • With significant or unexplained bleeding, black stools, vomiting/coughing blood, head injury, sudden chest pain, breathing trouble or neurological symptoms, use local urgent and medical pathways; do not infer continuation, pause or make-up use from this page.

Reviewed presentation examples — compare every field

  • 5 mg labelled per tablet; 30-tablet bottle (U.S. label)NDC 0713-0881-30
  • 10 mg labelled per tablet; 30-tablet bottle (U.S. label)NDC 0713-0882-30

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-23
Source record
2 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image